ESC 365 - Fatal pulmonary hypertension in advanced lung adenocarcinoma: a possible complication of serial tyrosine kinase inhibitor therapy

CCO Premium Access

Fatal pulmonary hypertension in advanced lung adenocarcinoma: a possible complication of serial tyrosine kinase inhibitor therapy

Session: From the clinic to Florence: experiences at the frontline of cardio-oncology (4)

Topic: Cardio-Oncology

Speaker: Doctor Y. Hung (Taipei, TW)

Event: ESC Cardio-Oncology 2025

Congress Presentation

Add to my library

About the speaker

Doctor Yi-Hsin Hung

National Taiwan University Hospital, Taipei (Taiwan)

2 presentations

0 follower

4 more presentations in this session

Heart transplantation as an effective alternative in the treatment of cardiotoxicity

Speaker: Mrs A. Nepomuceno Cunha (Sao Paulo, BR)

An immune checkpoint inhibitor-related effusive-constrictive pericarditis as a part of a wide range multi-organ immune-related phenomena

Speaker: Doctor D. Garcia Cosculluela (Terrassa, ES)

Managing ICI-myocarditis in metastatic melanoma: a case of steroid resistance and response to ruxolitinib

Speaker: Doctor K. Ozaeta (London, GB)

Primary cardiac lymphoma presenting as acute coronary syndrome and complete heart block - nodal disease of a different type.

Speaker: Doctor A. Kulek (Stony Brook, US)

Access the full session

From the clinic to Florence: experiences at the frontline of cardio-oncology (4)

Speakers: Doctor Y. Hung, Mrs A. Nepomuceno Cunha, Doctor D. Garcia Cosculluela, Doctor K. Ozaeta, Doctor A. Kulek

About the event

ESC Cardio-Oncology 2025

20 June - 21 June 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources